DK2158921T3 - Intranasal influenzavaccine baseret på virosomer - Google Patents

Intranasal influenzavaccine baseret på virosomer

Info

Publication number
DK2158921T3
DK2158921T3 DK09178084.1T DK09178084T DK2158921T3 DK 2158921 T3 DK2158921 T3 DK 2158921T3 DK 09178084 T DK09178084 T DK 09178084T DK 2158921 T3 DK2158921 T3 DK 2158921T3
Authority
DK
Denmark
Prior art keywords
virosomes
influenza vaccine
vaccine based
intranasal influenza
intranasal
Prior art date
Application number
DK09178084.1T
Other languages
English (en)
Inventor
Alexander J Kersten
Lisya Gerez
Pieter J Schoen
Jozef J P Nauta
Rheineck Leyssius Dorine Van
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Application granted granted Critical
Publication of DK2158921T3 publication Critical patent/DK2158921T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK09178084.1T 2006-03-22 2007-03-21 Intranasal influenzavaccine baseret på virosomer DK2158921T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78446206P 2006-03-22 2006-03-22
EP06111534 2006-03-22
EP07727166A EP1996229B1 (en) 2006-03-22 2007-03-21 Intranasal influenza vaccine based on virosomes

Publications (1)

Publication Number Publication Date
DK2158921T3 true DK2158921T3 (da) 2012-05-07

Family

ID=38038698

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07727166.6T DK1996229T3 (da) 2006-03-22 2007-03-21 Intranasal influenzavaccine baseret på virosomer
DK09178084.1T DK2158921T3 (da) 2006-03-22 2007-03-21 Intranasal influenzavaccine baseret på virosomer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07727166.6T DK1996229T3 (da) 2006-03-22 2007-03-21 Intranasal influenzavaccine baseret på virosomer

Country Status (21)

Country Link
EP (2) EP1996229B1 (da)
JP (1) JP5285595B2 (da)
KR (1) KR20090016659A (da)
AR (1) AR059972A1 (da)
AT (2) ATE451931T1 (da)
AU (1) AU2007228736B2 (da)
BR (1) BRPI0709864A2 (da)
CA (1) CA2646895A1 (da)
DE (1) DE602007003815D1 (da)
DK (2) DK1996229T3 (da)
EA (1) EA014532B1 (da)
ES (2) ES2338382T3 (da)
HR (2) HRP20100144T1 (da)
IL (1) IL193840A (da)
MY (1) MY142996A (da)
NO (1) NO20084452L (da)
PL (2) PL1996229T3 (da)
PT (2) PT2158921E (da)
SA (1) SA07280116B1 (da)
SI (2) SI1996229T1 (da)
WO (1) WO2007107585A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009276304B2 (en) * 2008-08-01 2012-10-11 Gamma Vaccines Pty Limited Influenza vaccines
BR112013010830A2 (pt) * 2010-11-02 2017-12-12 Hector Manuel Zepeda Lopez vacina inovadoras contra o vírus da influenza pandêmica a/h1n1
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
EP1447080A1 (en) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles
AR056245A1 (es) * 2003-06-19 2007-10-03 Bestewil Holding Bv Membranas virales reconstituidas funcionales que contienen un coadyuvante

Also Published As

Publication number Publication date
HRP20120013T1 (hr) 2012-01-31
JP5285595B2 (ja) 2013-09-11
PT1996229E (pt) 2010-03-16
WO2007107585A1 (en) 2007-09-27
PL2158921T3 (pl) 2012-06-29
BRPI0709864A2 (pt) 2011-07-26
EP2158921A1 (en) 2010-03-03
EP2158921B1 (en) 2012-01-04
PT2158921E (pt) 2012-03-27
ES2375436T3 (es) 2012-02-29
SI1996229T1 (sl) 2010-04-30
EA014532B1 (ru) 2010-12-30
CA2646895A1 (en) 2007-09-27
DE602007003815D1 (en) 2010-01-28
EP1996229A1 (en) 2008-12-03
EP1996229B1 (en) 2009-12-16
ATE539766T1 (de) 2012-01-15
AU2007228736A1 (en) 2007-09-27
MY142996A (en) 2011-02-14
HRP20100144T1 (hr) 2010-04-30
ES2375436T8 (es) 2012-03-15
SI2158921T1 (sl) 2012-03-30
SA07280116B1 (ar) 2010-10-19
AR059972A1 (es) 2008-05-14
ATE451931T1 (de) 2010-01-15
JP2009530351A (ja) 2009-08-27
EA200870361A1 (ru) 2009-02-27
IL193840A (en) 2011-10-31
NO20084452L (no) 2008-10-22
ES2338382T3 (es) 2010-05-06
DK1996229T3 (da) 2010-05-03
KR20090016659A (ko) 2009-02-17
IL193840A0 (en) 2011-08-01
AU2007228736B2 (en) 2011-12-15
PL1996229T3 (pl) 2010-05-31

Similar Documents

Publication Publication Date Title
DK2043682T3 (da) Influenzavaccine
ATE450271T1 (de) Impfstoff
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
DK1968631T3 (da) Vaccine
DK2049559T3 (da) Forbedrede HPV vacciner
DK2200646T3 (da) RNA-Vacciner
IL196024A0 (en) Influenza vaccine
CR10571A (es) Vacuna virica recombinante
BRPI0909770A2 (pt) Vacina, e, kit
DK2114993T3 (da) Vaccine
DK1942933T3 (da) Hundeinfluenzavacciner
BRPI0821034A2 (pt) Vírus influenza modificado
DK2090318T3 (da) Profylaktisk tuberkulosevaccine
DK1996229T3 (da) Intranasal influenzavaccine baseret på virosomer
DK2175881T3 (da) Intradermal influenzavaccine
HK1128077A1 (en) Intranasal influenza vaccine based on virosomes
ZA200900062B (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
GB0619090D0 (en) Influenza vaccine
GB0625453D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
CN300952823S (zh) 风扇底座(fts30-8a)
CN300939570S (zh) 风扇底座(ft-8k)
CN300939537S (zh) 风扇底座(fts40-7n)